RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ARTIOLI G
Collezione AO Ordine Mauriziano

Items : 9

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 May 1;42(13):1488-1498. doi: 10.1200/JCO.23.01225. Epub 2024 Feb 5.

2024
AO Ordine Mauriziano

Giolitto S; Scambia G; Greco F; Lorusso D; Raspagliesi F; Ronzulli D; Valabrega G; Colombo N; Pisano C; Salutari V; Frassoldati A; Ceccherini R; Casanova C; Andreetta C; Artioli G; Breda E; Mosconi AM; Mammoliti S; De Giorgi U; Mangili G; Tamberi S; Tognon G; Cassani C;

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;203:114039. doi: 10.1016/j.ejca.2024.114039. Epub 2024 Mar 30.

2024
AO Ordine Mauriziano

Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Pignata S; Valabrega G; Azzolina C; Geninatti E; Mantiero M; Ferrandina G; Carbone V; Rognone C; Borsotti L; Bellero M; Cioffi R;

Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society. in Tumori / Tumori. 2023 Oct;109(5):490-495. doi: 10.1177/03008916221146820. Epub 2023 Jan 6.

2023
ASL Torino 5
AO Ordine Mauriziano

Artioli G; Valabrega G; Purro A; Milani A; Scotto G; Turinetto M; Bellero M; Mammoliti S; Testa S; Mangili G; Di Maio M; Savarese A; Biglia N; Lorusso D; Scandurra G; Castaldo D; De Giorgi U; Pignata S; Tuninetti V;

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. in Cancers / Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Valabrega G; Di Maio M; Sangiolo D; Scotto G; Turinetto M; Borsotti L; Paolini B; Puppo A; Marinaccio M; Carella C; Cormio G; Parisi A; Mandato VD; Biglia N; Zanchi L; Sikokis A; Mammoliti S; Artioli G; Maldi E; Andreetta C; Raspagliesi F; Picardo E; Ghisoni E; Pignata S; Tuninetti V;

MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. in Cancers / Cancers (Basel). 2023 Dec 20;16(1):41. doi: 10.3390/cancers16010041.

2023
AOU Città della Salute di Torino
AO Ordine Mauriziano

Valabrega G; Scambia G; Pignata S; Scotto G; Tuninetti V; Bergamini A; Picardo E; Palaia I; Vertechy L; Artioli G; Parisi A; Scandurra G; Scollo P; Baldoni A; Malaguti P; Cassani C; Zamagni C; Ricotti A; Marchetti C; Pisano C; Turinetto M;

Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study. in Gynecologic oncology / Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22.

2023
ASL Biella
AO Ordine Mauriziano

Pignata S; Tomao F; Valabrega G; Zavallone L; Tasca G; Salutari V; Scandurra G; Savarese A; Sambataro D; Petrella MC; Ricciardi GRR; Ronzino G; Naglieri E; Mangili G; Mammoliti S; Lissoni A; De Angelis C; Legge F; Cormio G; Cecere SC; Ceccherini R; Landoni F; Lorusso D; Sabbatini R; Artioli G; Berardi R; Colombo N; Gadducci A;

Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2023 Sep 14;13:1247291. doi: 10.3389/fonc.2023.1247291. eCollection 2023.

2023
AO Ordine Mauriziano

Mangili G; Artioli G; Mammoliti S; Bartoletti M; Arezzo F; Tuninetti V; Scotto G; Giannone G; Castaldo D; Turinetto M; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. in Frontiers in oncology / Front Oncol. 2022 May 27;12:880008. doi: 10.3389/fonc.2022.880008. eCollection 2022.

2022
AO Ordine Mauriziano

Pignata S; Valabrega G; Ronzino G; Pisano C; Di Maio M; Savarese A; Zamagni C; Artioli G; Lorusso D; Cormio G; Salutari V; Mangili G; Mammoliti S; Bartoletti M; Valsecchi AA; Turinetto M; Scotto G; Tuninetti V; Giannone G; Castaldo D;

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2021 Jun;31(6):875-882. doi: 10.1136/ijgc-2021-002434. Epub 2021 Apr 30.

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pignata S; Perrone F; Gallo C; Arenare L; Giannone G; Fossati R; Piccirillo MC; Greggi S; Distefano M; Bogani G; Nardin M; Zaccarelli E; Cecere SC; Salutari V; Lorusso D; Katsaros D; Lissoni AA; De Giorgi U; Breda E; Scollo P; De Censi A; Cinieri S; Ferrero A; Lauria R; Gadducci A; Tognon G; Artioli G; Frezzini S; Colombo N; et alii...